fenofibrate has been researched along with cinnarizine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Doak, AK; Prusiner, SB; Shoichet, BK; Wille, H | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Fatouros, DG; Jacobsen, F; Kleberg, K; Müllertz, A | 1 |
| Porter, CJ; Trevaskis, NL; Yeap, YY | 1 |
| Boyd, BJ; Hawley, A; Jannin, V; Pouton, C; Vithani, K | 1 |
| Basit, AW; Boyd, BJ; Gaisford, S; Goyanes, A; Jannin, V; Vithani, K | 1 |
| Bergonzi, A; Clasen, C; Koekoekx, R; Michiels, E; Pas, T; Rousseau, F; Schymkowitz, J; Van den Mooter, G; Vergauwen, B | 1 |
| Brinkmann, J; Luebbert, C; Rest, F; Sadowski, G | 1 |
| Bauer-Brandl, A; Brandl, M; Eriksen, JB; Holsæter, AM; Lynnerup, JT | 1 |
14 other study(ies) available for fenofibrate and cinnarizine
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Colloid formation by drugs in simulated intestinal fluid.
Topics: Buffers; Chemical Precipitation; Colloids; Intestine, Small; Light; Microscopy, Electron, Transmission; Pharmaceutical Preparations; Scattering, Radiation; Solubility | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity.
Topics: Algorithms; Bile; Body Fluids; Chromatography, High Pressure Liquid; Cinnarizine; Colloids; Danazol; Emulsions; Fatty Acids, Nonesterified; Fenofibrate; Intestinal Mucosa; Light; Micelles; Microscopy, Electron, Transmission; Monoglycerides; Particle Size; Scattering, Radiation; Solubility; Solutions; Surface Tension | 2010 |
The potential for drug supersaturation during intestinal processing of lipid-based formulations may be enhanced for basic drugs.
Topics: Animals; Chemistry, Pharmaceutical; Cinnarizine; Colloids; Danazol; Fenofibrate; Intestinal Mucosa; Kinetics; Male; Models, Theoretical; Phenanthrenes; Rats; Rats, Sprague-Dawley; Solubility | 2013 |
Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Topics: Biological Availability; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cinnarizine; Crystallization; Drug Delivery Systems; Emulsions; Fenofibrate; Glycerides; Humans; Lipids; Polyethylene Glycols; Scattering, Radiation; Scattering, Small Angle; Solubility; Spectrum Analysis, Raman; Water | 2018 |
A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
Topics: Cinnarizine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fenofibrate; Kinetics; Lipids; Polyethylene Glycols; Printing, Three-Dimensional; Proof of Concept Study; Solubility; Surface-Active Agents; Water | 2019 |
Preparation of Amorphous Solid Dispersions by Cryomilling: Chemical and Physical Concerns Related to Active Pharmaceutical Ingredients and Carriers.
Topics: Cinnarizine; Crystallization; Drug Carriers; Drug Compounding; Drug Stability; Dynamic Light Scattering; Fenofibrate; Gelatin; Glass; Hypromellose Derivatives; Indomethacin; Molecular Structure; Molecular Weight; Naproxen; Povidone; Serum Albumin, Bovine; Solubility; Spectroscopy, Fourier Transform Infrared; Transition Temperature; Viscosity | 2020 |
Solubility of Pharmaceutical Ingredients in Natural Edible Oils.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cinnarizine; Coconut Oil; Drug Compounding; Drug Delivery Systems; Excipients; Felodipine; Fenofibrate; Griseofulvin; Ibuprofen; Indomethacin; Models, Molecular; Naproxen; Plant Oils; Solubility; Soybean Oil; Spectrum Analysis, Raman; Thermodynamics; Transition Temperature; Triglycerides | 2020 |
Insight into the mechanism behind oral bioavailability-enhancement by nanosuspensions through combined dissolution/permeation studies.
Topics: Administration, Oral; Biological Availability; Cinnarizine; Fenofibrate; Nanoparticles; Particle Size; Pharmaceutical Preparations; Solubility | 2023 |